Gene · 4773
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy. | Front Oncol | 2023 | 36998461 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals the interaction between peripheral CD4+ CTLs and mesencephalic endothelial cells mediated by IFNG in Parkinson's disease. | Comput Biol Med | 2023 | 36989741 | PubTator, text mining | PubMed |
| Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. | Int J Mol Sci | 2023 | 36982651 | PubTator, text mining | PubMed |
| Associations of T-Cell Receptor Repertoire Diversity with L-Asparaginase Allergy in Childhood Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2023 | 36980715 | PubTator, text mining | PubMed |
| How CD4+ T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation Assays. | Biomedicines | 2023 | 36979867 | PubTator, text mining | PubMed |
| Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives. | Biomedicines | 2023 | 36979668 | PubTator, text mining | PubMed |
| Strontium Ranelate Inhibits Osteoclastogenesis through NF-κB-Pathway-Dependent Autophagy. | Bioengineering (Basel) | 2023 | 36978756 | PubTator, text mining | PubMed |
| Novel role for linear ubiquitination in regulating NFAT1 stability. | FEBS J | 2023 | 36974504 | PubTator, text mining | PubMed |
| WNT16b promotes the proliferation and self-renewal of human limbal epithelial stem/progenitor cells via activating the calcium/calcineurin A/NFATC2 pathway. | Cell Prolif | 2023 | 36974338 | PubTator, text mining | PubMed |
| Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 36969884 | PubTator, text mining | PubMed |
| Non-canonical Wnt/Ca2+ signaling is essential to promote self-renewal and proliferation in colon cancer stem cells. | Front Oncol | 2023 | 36969011 | PubTator, text mining | PubMed |
| Extracellular matrix stiffness-The central cue for skin fibrosis. | Front Mol Biosci | 2023 | 36968277 | PubTator, text mining | PubMed |
| The effects of MYC on tumor immunity and immunotherapy. | Cell Death Discov | 2023 | 36966168 | PubTator, text mining | PubMed |
| Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. | Signal Transduct Target Ther | 2023 | 36964133 | PubTator, text mining | PubMed |
| Effective Molecular Dynamics from Neural Network-Based Structure Prediction Models. | J Chem Theory Comput | 2023 | 36961997 | PubTator, text mining | PubMed |
| T lymphocyte characteristics and immune repertoires in the epicardial adipose tissue of heart failure patients. | Front Immunol | 2023 | 36960061 | PubTator, text mining | PubMed |
| FOXP1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression. | PLoS One | 2023 | 36952469 | PubTator, text mining | PubMed |
| Endothelial KCa3.1 and KCa2.3 Mediate S1P (Sphingosine-1-Phosphate)-Dependent Vasodilation and Blood Pressure Homeostasis. | Arterioscler Thromb Vasc Biol | 2023 | 36951065 | PubTator, text mining | PubMed |
| Regulation and Immunotherapeutic Targeting of the Epigenome in Exhausted CD8 T Cell Responses. | J Immunol | 2023 | 36947818 | PubTator, text mining | PubMed |
| Longitudinal multi-omic changes in the transcriptome and proteome of peripheral blood cells after a 4 Gy total body radiation dose to Rhesus macaques. | BMC Genomics | 2023 | 36944971 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4773/papers?page=18